ARVO 2024

If you have planned to attend ARVO 2024 in Seattle, we warmly invite you to visit Imagine Eyes’ booth #1807 to discover our solutions for cellular-resolution retinal imaging, and our latest advances.

rtx1 AO retinal camera

The extraordinary resolution of adaptive optics (AO) with a device designed for clinical settings. Proven by 250+ publications, rtx1 reveals microscopic lesions and minute progressions through quick exams. It provides biomarkers of photoreceptor cells, RPE cells and microvascular alterations, and captures the RPE layer with unprecedented level of detail.

rtx1 comes to ARVO with new features that facilitate and standardize rtx1 examinations for clinical studies and trials.
We will be happy to introduce it with with live demos.

For trial sponsors and CROs

We offer global services for a successful implementation of AO biomarkers in studies and trials, thanks to our partner Emsere. Schedule a meeting at ARVO to discuss how to accelerate your developments in macular degenerations.

For developers of new technology

We propose customized AO modules, ready for integration in experimental ophthalmic systems. AOkit, our complete set of AO components designed for use with real eyes, is also as a cost-effective solution. It includes µDM, the latest deformable mirror in our line that was introduced last year.

 


New in AO imaging at ARVO 2024

Visit Imagine Eyes’ booth #1807 to discover how the latest features for the rtx1 AO retinal camera streamline its implementation in clinical studies and trials, and enables new discoveries.

Imaging the retina pigmented epithelium

Introduced last year on the market, TFI is an optional add-on for the rtx1 AO camera, for imaging the RPE layer at the microscopic scale. It is compatible with most existing devices.

Multi-acquisition protocols

This powerful functionality guides users through every step of virtually any AO imaging procedure. It enables accelerating baseline and follow-up visits, and even standardizing rtx1 examinations in multicentric studies.

Investigate new candidate biomarkers

New examinations procedures added to rtx1 enable new investigations of the retinal tissue and alterations in diseases:

  • Flicker stimulation – for assessing neurovascular response with micron precison.
  • Gaze-dependent procedure – to investigate small drusen.
  • Directional imaging – to explore directional changes in photoreceptor reflectance.

Large AO images in 1 click

Our images are supported by the ultra-fast stiching algorithms from DualAlign. We have streamlined the workflow for building and revewing AO montages, to facilitate data interpretation.

And more at booth #1807

Our experts will be happy to provide live demos!


ARVO 2024 program highlights on Imagine Eyes’ rtx1 camera

This year, users of rtx1 AO cameras will introduce new biomarkers for assessing photoreceptors, RPE cells, pigment redistibution and neurovascular coupling in clinical studies. 11 posters and presentations report new findings in non-exudative AMD, inherited retinal diseases, retinal detachment, and diabetic retinopathy.

Sunday, May 5

  • Poster B0547:
    Adaptive Optics Imaging in Retinal Detachment: A Retrospective Analysis.
    Andrew Mihalache (University of Toronto Temerty Faculty of Medicine, Canada)
  • Poster B0644:
    Automated segmentation of cone photoreceptors in AO-FIO: a multi-center study.
    Danilo Andrade De Jesus (Erasmus MC Rotterdam, Netherlands)

Monday, May 6

  • Presentation in session ‘Progress on adaptive optics imaging’:
    Comparing two adaptive optics imaging methods of retinal pigmented epithelial (RPE) cells.
    Kiyoko Gocho (Quinze-Vingts National Eye Hospital & INSERM, France)
  • Poster A0159:
    Adaptive optics in patients with early-onset macular degeneration.
    Mahfam Shahabi (Radboud UMC, Netherlands)
  • Poster A0167:
    Hyperpigmented spots during enlargement of geographic atrophy.
    Michel Paques (Quinze-Vingts National Eye Hospital, France)

Tuesday, May 7

  • Presentation in session ‘AMD imaging II’:
    Using adaptive optics to assess hyporeflective clumps as a biomarker for progression to cRORA in the PINNACLE study.
    Christopher Holmes (Moorfields Eye Hospital NHS Foundation Trust, United Kingdom)
  • Poster A0310:
    Blood vessel morphology evaluation in inherited retinal dystrophies.
    Katarzyna Samelska (Medical University of Warsaw, Poland)
  • Poster A0313:
    Neurovascular coupling reflex: contralateral hardware stimulation setup and coupling index determination.
    Rui Bernardes (University of Coimbra, Portugal)
  • Poster A0351:
    Retinal arterial lumen diameter is reduced and wall thickness is not altered in eyes with retinitis pigmentosa.
    Junya Ota (Nagoya University Hospital, Japan).

Thursday, May 9

  • Poster B0530:
    Adaptive optics (AO) retinal imaging delineates retinal changes in patients at all ETDRS stages of diabetic macular ischemia, undetectable by other structural and functional imaging in mild to moderate ischemia.
    Nick Muthiah (University College London Institute of Ophthalmology, United Kingdom)
  • Poster B0877:
    Phenotypic Variability and Evolution of MFSD8-related Retinal Disease.
    Manon Van Haute (Ghent University Hospital, Belgium)

 


Schedule your in-person meeting with Imagine Eyes at ARVO 2024